Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
468.36
+1.14 (0.24%)
At close: Apr 15, 2026, 4:00 PM EDT
468.36
0.00 (0.00%)
After-hours: Apr 15, 2026, 4:51 PM EDT
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 |
Instruments & Accessories Revenue | 1.66B | |||||||||||||||||||||||
Instruments & Accessories Revenue Growth | 17.48% | |||||||||||||||||||||||
Systems Revenue | 785.90M | |||||||||||||||||||||||
Systems Revenue Growth | 20.06% | |||||||||||||||||||||||
Product Revenue | 2.44B | |||||||||||||||||||||||
Product Revenue Growth | 18.30% | |||||||||||||||||||||||
Services Revenue | 422.00M | |||||||||||||||||||||||
Services Revenue Growth | 21.47% | |||||||||||||||||||||||
Revenue (Total) | 2.87B | |||||||||||||||||||||||
Revenue (Total) Growth | 18.76% |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 |
U.S. Revenue | 1.93B | |||||||||||||||||||||||
U.S. Revenue Growth | 16.84% | |||||||||||||||||||||||
OUS Revenue | 935.60M | |||||||||||||||||||||||
OUS Revenue Growth | 22.91% | |||||||||||||||||||||||
Revenue (Total) | 2.87B | |||||||||||||||||||||||
Revenue (Total) Growth | 18.76% |
Gross Profit
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 |
Product Gross Profit | 1.63B | |||||||||||||||||||||||
Product Gross Profit Growth | 16.56% | |||||||||||||||||||||||
Services Gross Profit | 269.90M | |||||||||||||||||||||||
Services Gross Profit Growth | 12.46% | |||||||||||||||||||||||
Gross Profit (Total) | 1.90B | |||||||||||||||||||||||
Gross Profit (Total) Growth | 15.96% |
Key Performance Indicators
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 |
Operating Lease Revenue | 242.30M | |||||||||||||||||||||||
Operating Lease Revenue Growth | 33.50% | |||||||||||||||||||||||
Total Recurring Revenue | 2.32B | |||||||||||||||||||||||
Total Recurring Revenue Growth | 19.70% | |||||||||||||||||||||||
Da Vinci Systems Installed Base | 11.11K | |||||||||||||||||||||||
Da Vinci Systems Installed Base Growth | 12.16% | |||||||||||||||||||||||
Da Vinci Procedures Performed | 849.00K | |||||||||||||||||||||||
Da Vinci Procedures Performed Growth | 17.10% | |||||||||||||||||||||||
Ion Procedures Performed | 40.20K | |||||||||||||||||||||||
Ion Procedures Performed Growth | 44.60% | |||||||||||||||||||||||
U.S. Da Vinci Surgical System Unit Placements | 304.00 | |||||||||||||||||||||||
U.S. Da Vinci Surgical System Unit Placements Growth | 7.04% | |||||||||||||||||||||||
OUS Da Vinci Surgical System Unit Placements | 228.00 | |||||||||||||||||||||||
OUS Da Vinci Surgical System Unit Placements Growth | 9.09% | |||||||||||||||||||||||
Da Vinci Surgical System Unit Placements Involving Trade-Ins | 146.00 | |||||||||||||||||||||||
Da Vinci Surgical System Unit Placements Involving Trade-Ins Growth | 135.48% | |||||||||||||||||||||||
Da Vinci Surgical System Unit Placements Not Involving Trade-Ins | 386.00 | |||||||||||||||||||||||
Da Vinci Surgical System Unit Placements Not Involving Trade-Ins Growth | -10.44% | |||||||||||||||||||||||
Total Da Vinci Surgical System Unit Placements | 532.00 | |||||||||||||||||||||||
Total Da Vinci Surgical System Unit Placements Growth | 7.91% | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Fixed-Payment Operating Lease Arrangements | 100.00 | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Fixed-Payment Operating Lease Arrangements Growth | 21.95% | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Usage-Based Operating Lease Arrangements | 150.00 | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Usage-Based Operating Lease Arrangements Growth | 7.14% | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Operating Lease Arrangements | 250.00 | |||||||||||||||||||||||
Da Vinci Surgical System Placements Under Operating Lease Arrangements Growth | 12.61% | |||||||||||||||||||||||
Total Ion System Placements | 42.00 | |||||||||||||||||||||||
Total Ion System Placements Growth | -39.13% | |||||||||||||||||||||||
Ion System Placements Under Fixed-Payment Operating Lease Arrangements | 5.00 | |||||||||||||||||||||||
Ion System Placements Under Fixed-Payment Operating Lease Arrangements Growth | -79.17% | |||||||||||||||||||||||
Ion System Placements Under Usage-Based Operating Lease Arrangements | 11.00 | |||||||||||||||||||||||
Ion System Placements Under Usage-Based Operating Lease Arrangements Growth | -21.43% | |||||||||||||||||||||||
Ion System Placements Under Operating Lease Arrangements | 16.00 | |||||||||||||||||||||||
Ion System Placements Under Operating Lease Arrangements Growth | -57.89% |
Updated Jan 22, 2026. Data Source: Fiscal.ai.